Delivery Order SPE2DB24D2101-SPE2DB25FKJLY

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 mL vials of the pharmaceutical product Ferumoxytol, with a ceiling value of $2,434.84 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 mL vials of the drug Ferumoxytol, with a ceiling value of $4,032.21 and a period of performance through May 28, 2025. The contract is a firm fixed price arrangement and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product. The contract has a ceiling value of $3,146.04 and is a firm fixed price delivery order, with a performance period ending on May 23, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a for-profit organization that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 ml vials of the drug ferumoxytol, a medication used to treat iron deficiency anemia. The contract has a ceiling value of $5,071.17 and a period of performance through April 16, 2025. It is a firm-fixed price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division provides for the supply of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, to the U.S. government. The $1,349.80 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary procurement vehicle for the Department of Defense (DoD) to acquire medical commodities. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 17 mL vials of the injectable iron replacement medication ferumoxytol. The $13,498 firm fixed price contract has a period of performance through September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and other healthcare providers. The...
This is a $3,875.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565732241 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of September 10, 2024. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a medical product used for the treatment of iron deficiency anemia. The contract has a ceiling value of $2,398.60 and a period of performance through May 22, 2025. This contract is not designated as a set-aside. AmerisourceBergen...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKJLY
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 510 mg/17 ml ferumoxytol vials. The contract has a ceiling value of $3,166.67 and a performance period through April 11, 2025. This award is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:30 PM